Molecular surveillance of pfhrp2 and pfhrp3 deletions in Plasmodium falciparum isolates from Mozambique

Malar J. 2017 Oct 16;16(1):416. doi: 10.1186/s12936-017-2061-z.

Abstract

Background: Malaria programmes use Plasmodium falciparum histidine-rich protein-2 (PfHRP2) based rapid diagnostic tests (RDTs) for malaria diagnosis. The deletion of this target antigen could potentially lead to misdiagnosis, delayed treatment and continuation of active transmission.

Methods: Plasmodium falciparum isolates (n = 1162) collected in Southern Mozambique were assessed by RDTs, microscopy and/or 18SrRNA qPCR. pfhrp2 and pfhrp3 deletions were investigated in isolates from individuals who were negative by RDT but positive by microscopy and/or qPCR (n = 69) using gene-specific PCRs, with kelch13 PCR as the parasite DNA control.

Results: Lack of pfhrp2 PCR amplification was observed in one of the 69 isolates subjected to molecular analysis [1.45% (95% CI 0.3-7.8%)].

Conclusions: The low prevalence of pfhrp2 deletions suggests that RDTs will detect the vast majority of the P. falciparum infections. Nevertheless, active surveillance for changing deletion frequencies is required.

Keywords: Deletion; Malaria; Mozambique; Pfhrp2; RDT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence*
  • Antigens, Protozoan / genetics*
  • Diagnostic Errors / statistics & numerical data
  • Diagnostic Tests, Routine
  • Malaria, Falciparum / diagnosis*
  • Mozambique
  • Plasmodium falciparum / genetics*
  • Protozoan Proteins / genetics*
  • Sequence Deletion*

Substances

  • Antigens, Protozoan
  • HRP-2 antigen, Plasmodium falciparum
  • HRP3 protein, Plasmodium falciparum
  • Protozoan Proteins